EGEN-5784 (genetically engineered porcine liver) + metra® Extracorporeal Liver Cross-Circulation (ELC) system (OrganOx) for acute-on-chronic liver failure

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Feb 2026: Trial registered, NCT07429838

The trials

NCT07429838: RENEW: Study of Porcine Liver Support in Participants With Acute-on-Chronic Liver Failure

State
Not started
Phase
Phase 1 and Phase 2
People
20 planned
Started
Oct 2026
Primary completion
Dec 2027
Arms
EGEN-5784 + metra® Extracorporeal Liver Cross-Circulation (ELC)
Results
None posted
  1. 24 Feb 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.